FCGR2B and Guillain-Barre syndrome: Variations in FCGR2B (encoding the inhibitory FcγRIIb), FCGR2C (encoding FcγRIIc, expressed in approx. 10% of individuals), as well as CNVs, have not been previously investigated in GBS.